MarketResearchReports.com: Asia Pacific to Lead Global Earthmoving Equipment Industry, Finds New Report

The global earthmoving equipment market valued US$78.7 billion in 2011, of which the Asia-Pacific market constituted a 57.8% share, making it the largest regional market for earthmoving equipment in the world. In the same year, markets in Europe and North America positioned themselves as the second and third-largest regional markets, with 22.0% and 12.4% shares respectively. The continuing economic uncertainty in Europe and sluggish growth in the US are expected to reduce the market shares of western regions. Growing economies in Asia-Pacific, in particular China and India, are expected to increase their market shares as the rapid development of their infrastructural, industrial, residential and commercial sectors increases the demand for construction equipment. The share of European and North American markets is expected to be 18.2% and 9.8% respectively in 2016, declining from 22.0% and 12.4% in 2011, while Asia-Pacific is forecast to increase its share to 64.5% in the same year.

This report provides detailed market analysis, information, trends, issues and insights into the global earthmoving equipment market, including:-

  • The regional and global earthmoving equipment market’s growth prospects by category.
  • Analysis of the Asia-Pacific, Middle East, North American, Latin American and European markets separately with country level data.
  • Critical insight into the impact of the market through comparative analysis of country level data.
  • Company profiles of key companies operating in the earthmoving equipment industry.

This report provides a comprehensive analysis of the earthmoving equipment market globally:-

  • Historical (2007-2011) and forecast (2012-2016) valuations of the earthmoving equipment market in Asia-Pacific, Middle East, Europe, North America, Latin America
  • Historical and forecast valuations for the segments of the earthmoving equipment market including Bulldozers, Excavators, Dumper Trucks, Construction Tractors, Graders and Levelers, Loaders and Scrapers
  • Breakdown of values at the country level (44 countries)
  • Analysis of key events and factors driving the earthmoving equipment market globally

Reasons To Buy

  • Assess market growth potential at a micro-level via review data and forecasts at category and country level
  • Understand the latest industry and market trends
  • Formulate and validate business strategies by leveraging our critical and actionable insight
  • Assess business risks, including cost and competitive pressures

Key Highlights

  • The global earthmoving equipment market valued US$78.7 billion in 2011, of which the Asia-Pacific market constituted a 57.8% share, making it the largest regional market for earthmoving equipment in the world.
  • In terms of growth, the global earthmoving equipment market recorded a CAGR of 2.50% during the review period (2007-2011). The key contributor to this low growth rate was the 23.9% decline in annual growth rate recorded in 2009.
  • The Asian earthmoving equipment market valued US$45.5 billion in 2011. The Chinese market constituted the largest share with 56.9%.
  • A strong pipeline of various infrastructure, industrial, residential, commercial and institutional construction projects in Asia-Pacific will drive demand for earthmoving equipment. As a result, the global earthmoving equipment market is estimated to record a CAGR of 7.98% over the forecast period to value US$115.5 billion in 2016.
  • China is one of the fastest-growing construction equipment markets in the world. In terms of total global sales of construction equipment, the share of China’s construction equipment sales increased from 9% in 2005 to 40% in 2010.

Spanning over 222 pages and 222 tables, “Global Earthmoving Equipment – Market Opportunity and Environment, Analyses and Forecasts to 2016” report identify and evaluate market opportunities using our standardized valuation and forecasting methodologies.

In addition to covering the Global Earthmoving Equipment Market Analysis, North America, Europe, Asia-Pacific, Latin America, Middle East, Company Profile: AB Volvo, Company Profile: Caterpillar Inc., Company Profile: Mitsubishi Heavy Industries, Ltd, Company Profile: Hyundai Heavy Industries Co., Ltd, Company Profile: Komatsu Ltd, Company Profile: Hitachi Construction Machinery Co., Ltd, Company Profile: Doosan Infracore Co., Ltd, Company Profile: BEML Ltd, Company Profile: Escorts Ltd, Company Profile: Telco Construction Equipment Company Ltd.

For more information visit:  Global Earthmoving Equipment – Market Opportunity and Environment, Analyses and Forecasts to 2016

Related reports-

Global Cranes, Lifting and Handling Equipment – Market Opportunity and Environment, Analyses and Forecasts to 2016

Concrete and Cement in BRIC to 2016: Market Databook

Find all Industry and Manufacturing Market Research Reports under a single page at: Industry and Manufacturing Market Research Reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Government of South Africa to invest US$100.8 in construction industry over next few years

The South African construction industry recorded a CAGR of 13.72% during the review period. The construction industry output slowed following the 2010 FIFA World Cup, but has started to recover. Under the National Infrastructure Plan (NIP) that was adopted in 2012, the government will invest ZAR827 billion (US$100.8 billion) in infrastructure development over the forecast period. The country faces a substantial housing deficit and will need government support to develop public housing and drive the residential construction market. The industrial sector, which had benefitted from low wages, now faces labor unrest and will have to focus on increasing productivity to remain competitive. While the large number of projects announced provides hope for the construction industry, corruption, mismanagement and price fixing threaten to undermine the proper implementation of these developments. Publisher expects the South African construction industry to record a CAGR of 10.87% over the forecast period.

This report provides detailed market analysis, information and insights into the South African construction market, including:-

  • The South African construction market’s growth prospects by sector, project type and type of construction activity
  • Analysis of equipment, material and service costs across each project type within South Africa
  • Critical insight into the impact of industry trends and issues and the risks and opportunities they present to participants in the South African construction market
  • Assessment of the competitive forces facing the construction industry in South Africa and profiles of the leading players
  • Data highlights of the largest construction projects in South Africa

This report provides a comprehensive analysis of the construction industry in South Africa:-

  • Segmentation by sector (commercial, industrial, infrastructure, institutional and residential) and by project type
  • Breakdown of values within each project type, by type of activity (new construction, repair and maintenance, refurbishment and demolition) and by type of cost (materials, equipment and services)
  • Analysis of key construction industry issues, including regulation, cost management, funding and pricing
  • Assessment of the competitive environment using Porter’s Five Forces
  • Detailed profiles of the leading construction companies in South Africa

Reasons To Buy

  • Identify and evaluate market opportunities using our standardized valuation and forecasting methodologies
  • Assess market growth potential at a micro-level via 600+ time series data forecasts
  • Understand the latest industry and market trends
  • Formulate and validate business strategies by leveraging our critical and actionable insight
  • Assess business risks, including cost, regulatory and competitive pressures
  • Evaluate competitive risk and success factors

Key Highlights-

  • South Africa’s real GDP expanded at 2.5% in 2012, lower than the 3.5% recorded in 2011. Private consumption, which accounts for 60% of GDP, moderated from 4.8% in 2011 to 3.5% in 2012 due to rising inflation, which eroded household purchasing power. However, gross fixed capital formation growth accelerated from 4.5% in 2011 to 5.7% in 2012, as business sentiment improved in the second half of 2012. South Africa’s GDP growth is expected to moderate further to 1.9% in 2013, due to prevailing unrest in the mining and agricultural sectors, and a weaker export outlook.
  • South Africa’s construction industry underwent a period of weak performance during the review period as profit margins continued to decline. According to Statistics South Africa, the construction industry’s average profit margin plunged from 5% in 2009 to 2.8% in 2011.
  • Gauteng generated the most revenue for the construction industry in 2011, followed by the Western Cape. All other provinces increased their share of the total revenue generated.
  • While the demand for prime office space remains strong, overall demand for office space has declined. Developers are wary of speculative construction and the majority of projects are based on pre-let contracts. Retail sales growth also slowed over 2012, as consumer confidence dropped to its lowest mark during the review period.
  • Retail space development has largely been concentrated on upgrading existing properties, while the development pipeline for larger properties has slowed. Electricity price rises and expected increases in transport costs are likely to impact overall consumer spending. High unemployment rates, rising inflation and a slowdown in real income growth are affecting consumer confidence.
  • The country has a well-established and diversified manufacturing base, with agro-processing, automotives, chemicals, ICT, metals, textiles, clothing and footwear as primary industries. In April 2013, the South Africa’s Department of Trade and Industry (DTI) announced the fifth edition of the Industrial Policy Action Plan (IPAP), which will focus on  promoting stronger growth in the manufacturing sector. IPAP 2013 focuses on supporting high value-add industries such as green industries, agro-processing, metal fabrication, capital and transport equipment. IPAP 2013 should help drive industrial construction growth over the forecast period.
  • Under the National Infrastructure Plan (NIP) adopted in 2012, the government will invest ZAR827 billion (US$100.8 billion) in infrastructure development over the forecast period. ZAR430 billion (US$52.4 billion) will come from the government’s treasury with the remaining sum coming from state-owned enterprises such as Eskom and Transnet. The funding from state-owned enterprises will be invested in building new power stations, new transmission lines, new rail, ports, water-transport and various airport upgrades.
  • Despite an increase in education, budget and enrolment rates, the education system in general suffers from poor infrastructure and inequalities in the quality of education provided to rural and urban, and rich and poor regions. The government has allocated the largest share of its 2013 budget for education to improve infrastructure and increase accessibility.
  • The South African government is implementing reforms to restructure the South African health system. The healthcare buildings category is projected to be the fastest-growing institutional construction category over the forecast period.
  • South Africa witnessed a housing boom between 2000 and 2006. The housing boom in the country slowed down as the economy slowed, banks tightened lending conditions and the government implemented measures to limit household indebtedness. Low interest rates and government initiatives to increase mortgage uptake is expected to support the residential construction market. While house prices are expected to rise, real house price growth will be moderate, given continual increases in inflation.
  • The country presently faces a large affordable housing deficit. Infrastructure bottlenecks in many cities limit the capacity to deliver affordable and subsidized housing.

Spanning over 80 pages, 81 tables and 36 figures, “Construction in South Africa – Key Trends and Opportunities to 2017” report provide historical (2008-2012) and forecast (2013-2017) valuations of the construction market in South Africa using the construction output and value-add methods.

In addition to covering the Market Overview, Commercial Construction, Industrial Construction, Infrastructure Construction, Institutional Construction, Residential Construction, Company Profile: Aveng Ltd, Company Profile: Murray & Roberts Holdings Ltd, Company Profile: Wilson Bayly Holmes-Ovcon Ltd, Company Profile: Group Five Ltd, Company Profile: Basil Read Holdings Ltd, Market Data Analysis.

Related reports (10% off if bought together)

Global Roofing Products – Market Opportunity and Environment, Analyses and Forecasts to 2016

Global Cranes, Lifting and Handling Equipment – Market Opportunity and Environment, Analyses and Forecasts to 2016

Global Construction Aggregates Market – Key Trends and Opportunities to 2017

Global Construction Industry Survey 2013–2014: Market Trends, Marketing Spend and Sales Strategies in the Global Construction Industry

Find all Country Overview (Industry & Manufacturing) Research Reports under a single page at: Country Overview (Industry and Manufacturing)

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: 2020 Foresight Report: Wealth Management Business Models and Best Practices

Wealth management is one of the most promising segments of the global financial services sector due to the emerging markets in Asia and Latin America. However, downside risks have intensified due to financial crises, volatility in capital markets, the movement of capital to relatively safe assets and regions, and increased regulatory pressures and norms. Competitors specialize in various business models in order to cater to the diverse needs of high net worth individual (HNWI) clients. The segment’s participants differ in terms of size, corporate structure and clients. Such levels of diversification indicate that the wealth management segment can sustain a variety of profitable business models. For more information visit: 2020 Foresight Report: No Magic Bullet – Wealth Management Models

Wealth management business models differ in terms of firms, size, corporate structure, clients targeted and revenue generated. Many firms and organizations share common features in terms of their core activities, company history, operations and services, providing a basis for rudimentary or arbitrary business model classifications. It is possible to identify basic wealth management models based around banks or other custodial institutions; broker-dealers and stockbrokers; and investment managers and family offices. These models are not mutually exclusive. One by-product of financial integration means that wealth management firms with a banking background, often have both broking and investment management arms. Similarly, many broking firms have diversified into investment management and other activities to generate more reliable and higher-quality revenue streams.

Target audience

  • Wealth management companies
  • Contractor research organizations.
  • Academia or other industry observers
  • Marketing and advertising agencies

The report provides analysis, information and insights into wealth management models used by wealth management companies globally

  • The report provides a global snapshot of various wealth management business models adopted, their market size and future outlook.
  • The report provides a comprehensive analysis of the respective market size, future outlook and competitive landscape of leading wealth management companies.
  • The report provides an analysis of trends and drivers driving the growth of various wealth management models.
  • The report provides a detailed analysis of best practices adopted by various wealth management companies across wealth management models.

The wealth management segment emerged as significant to the financial sector in the late 1980s. Due to an increase in demand, the segment was equipped with a network of investment advisors. Global wealth management growth declined dramatically during 2009−2012 due to the US economic crisis, combined with the Eurozone debt crisis in 2011, resulted in high market volatility and minimal growth that swept away investor assets and deterred them from investing in stocks and bonds.

The Asia-Pacific’s HNWIs population recorded significant growth during 2008−2012 at a CAGR of 11.27%, increasing from 2.4 million people in 2008 to 3.7 million people in 2012. Japan was the largest HNWI consumer market and accounted for 52.3% of the region’s total HNWI population. China is the second-largest market followed by Australia with respective shares of 17% and 5.1%. During the forecast period, the number of HNWI customers in this region is forecast to increase from 3.9 million people in 2013 to 5.1 million people in 2017, at a CAGR of 6.87%.

In terms of HNWI wealth, the Latin American region recorded an impressive CAGR of 9.82% during the review period. The HNWI wealth of this region increased from US$19.7 trillion in 2008 to US$28.7 trillion in 2012. Over the forecast period, the value of HNWI wealth in this region is forecast to increase from US$30.1 trillion in 2013 to US$35.1 trillion in 2017, at a CAGR of 3.93%.

The wealth management segment in emerging economies has recorded a greater level of market penetration. The growth and development of the wealth management segment was led by the advent of advanced technology and cost of infrastructure. These market drivers result in conducting decisions in respect with growth and development of the industry enabling UHNWIs to invest appropriately. Australia adopted the highest market penetration rate at 6% with a total of 2,585 UHNWIs and 155 wealth management institutions followed by Poland which grew at a penetration rate of 3.1%. Poland comprises of a total of 15 wealth management institutions providing services to 487 UHNWIs.

Market penetration rates are nowhere near saturation level, even in the developed economies of North America and Europe. This has obvious implications for competition and, by design, wealth management business models. In many nations there are a substantial number of potential clients that meet the typical entry requirements for a private banking or wealth management service. This untapped or ‘latent’ market could support a large number of new entrants.

Consolidation and acquisition activities in the wealth management segment are being driven by developed economies such as the US and the UK. The US alone recorded more than 100 acquisition deals in 2012, of which 85 were wealth management related. A similar pattern was observed in the UK.

Reasons to Buy

  • Gain an insight into the different types of wealth management business models within the market.
  • Understand the best practices framework adopted by the wealth management segment.
  • Gain an upper hand on your competitors by reviewing a set of wealth management models including information on the competitive landscape and industry dynamics.
  • Obtain an understanding of the sizing of the world markets.

Spanning over 79 pages, 25 tables and 37 figures, “2020 Foresight Report: No Magic Bullet – Wealth Management Models” report provides a comprehensive analysis of wealth management models adopted by various wealth management companies in the financial services industry and provides information on current market size and future prospects of the wealth management industry in developed and emerging markets.

In addition to covering the Wealth Management Business Models, Best Practices Framework Adopted by Wealth Management Segment, Wealth Management Models-Competitive Landscape and Industry Dynamics, Market Sizing – Global Market Size, Asia-Pacific, Americas and Europe (Regional market size and forecast).  The report covers 6 companies; Barclays, BNP Paribas, Deutsche Bank, HSBC, UBS, RBC.

Related reports-

2020 Foresight Report: Social Media in Wealth Management

2020 Foresight Report: Branding and Segmentation in Wealth Management

2020 Foresight Report: Post Office Financial Services

2020 Foresight: Bancassurance

2020 Foresight Report: Reinsurance Hubs

Find all Banking & Finance industry reports under a single page at:  Banking and Finance Market Research Reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Customer Convenience and Reduction in cost Driving the Mobile Point of Sale (MPOS) Technology market

Initially mobile point of sale (MPOS) technology was targeted at small enterprises who could not afford a conventional point of sale (POS) solution, either because of financial restrictions or because of the mobile nature of their business operation. However, developments in the retail and service sectors suggest that the technology is not only making inroads into large stores but areas not previously outlined for its use. Demand is being driven by the number of benefits the technology offers, such as improved levels of customer service. MPOS solutions process card payments at anytime and in any location. During 2011-2012, the global MPOS industry registered significant growth in terms of the volume of terminals in operation, registering an annual growth of 111%. Driven by the high adoption in emerging markets, the industry is further expected to expand at a CAGR of 42.7% over the next four years. For more information visit: 2020 Foresight Report: Mobile Point of Sale Technology

The key factors that are driving MPOS growth are:

  • Increases customer convenience.
  • Reduction of cost.
  • Higher sales.
  • Ability to tap seasonal demand.
  • Competitive differentiation.
  • Affordability by micro and small business operators.
  • Flexibility of payment on the go.

Competitors such as Square, iZettle, mPowa, SumUp, VeriFone, Intuit and PayPal are aiding the growth of MPOS technology by making it accessible to smaller enterprises. Over the forecast period, the volume of terminals is expected to increase, driven by growth in the retail sector, increased online trade, a rise in smartphone usage and card penetration.

MPOS technology is spreading at a very fast pace across the key economic regions of the globe, including developed and emerging markets with a number of startup organizations as well as established players in the payment industry who have chosen to venture into this sector.

Countries like the US, Canada, the UK, Germany, Japan and Australia are current hotspots for MPOS technology due to high investment as well as favourable market drivers such as rising card penetration, smart-phone and internet users. The adoption of this technology in emerging economies such as India, China, Brazil and Russia is also beginning to catch up. They are fast becoming key areas of future investment due to a combination of the positive macroeconomic factors and the favourable demographics.

MPOS solutions have high adoption levels in more developed economies such as the UK, France and Germany with firms such as VeriFone, Square, Intuit, iZettle, PayPal and Motorola leading the charge. Countries in the Asia-Pacific region such as India, China, Malaysia, Singapore, and Hong Kong are now emerging as new destinations for investment in this technology.

Recent technological innovations have allowed turning smart-phones and tablets, which run on platforms such as Apple’s iOS, Blackberry and Android, to be used as MPOS systems. Many providers of MPOS solutions provide dongles, which can be attached to a smart-phone through the headphone jack, a USB port or a proprietary connector, capable of reading card information.

Reasons to buy

  • Receive a comprehensive analysis of the size and future growth prospects of the technology market.
  • Understand analysis on the various market drivers and key challenges.
  •  Understand detailed analysis of the business strategies adopted by key players in the market to expand their customer base and operations.
  • Review a global snapshot of MPOS technology and its adoption in various regions across the world.
  • Save funds by narrowing budget allocation for online and digital marketing.
  • Gain an edge by reviewing case studies showcasing the impact of MPOS adoption and detailed analysis of competitor landscape along with their business strategies.

Target audience

  • Financial service & MPOS companies.
  • Suppliers to financial service companies.
  • Contractor research organizations.
  • Trade body, academia or other industry observers
  • Companies involved at any stage in the manufacturing, procurement and marketing process.
  • Marketing and advertising agencies.
  • Technology Companies.

The market size of MPOS technology is growing at a fast pace. The key growth drivers are expected to comprise MPOS-enabled smartphones, investment in MPOS technology in the emerging economies of Asian and Africa, the large-scale adoption of MPOS technology by small enterprises and the clearance of regulatory hurdles.

The retail sector is considered the main area of adoption for MPOS services due to the volume of transactions. Even though the sector’s growth rate has been volatile due to the economic crises, the size of the sector has continued to expand.

Spanning over 81 pages, 2 tables and 48 figures, “ 2020 Foresight Report: Mobile Point of Sale Technology ” report provides a comprehensive analysis of mobile point of sale technology along with key drivers and challenges.

In addition to covering the Mobile Point of Sale Terminals (MPOS) Market Dynamics, Global Market Size and Drivers, MPOS Strategies, Implementing Mobile POS, Competitive Landscape and Industry Dynamics. The report covers 10 companies; Nordstrom, Nebraska Book Company, Gaylord Hotels, Motorola, VeriFone, Intuit, iZettle, Square, SumUp, The Home Depot.

Related reports-

Innovation in Payment Systems: The Emergence of Contactless Cards and Payments

2020 Foresight: Bancassurance

The Growing Opportunities in Money Transfer

Find all Banking & Finance industry reports under a single page at:  Banking and Finance Market Research Reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: 2020 Foresight Report: Cloud Technology and New Business Models Driving Card Outsourcing Market

Cards make up one of the most outsourced business operations in the financial services sector. Indeed, a large numbers of banks and card issuers have either outsourced specific functions or their entire their card operations. The primary factors driving such practice have been largely similar to those recorded in the outsourcing sector in general, and include cost reduction, gaining a comparative advantage, access to cheap/skilled labor, a lack of in-house expertise and risk management advantages. Card outsourcing is fast-moving towards the adoption of cloud technology and onshore and nearshore models, driven primarily by cost advantage and government initiatives such as tax benefits. In addition, there is an increased focus on value added services such as behavior analysis and fraud prevention schemes.

This report provides detailed insights into the following topics:

  • Card outsourcing models
  • Key offshore outsourcing locations
  • Emerging trends
  • Best practices in vendor management
  • Best practices in outsourcing of key business operations related to the card industry

Cards make up one of the most outsourced business operations in the financial services sector. A large numbers of banks and card issuers have either outsourced specific functions or their entire their card operations.

The primary factors driving card outsourcing have been largely similar to those recorded in the outsourcing sector in general, and include cost reduction, gaining a comparative advantage, access to cheap/skilled labor, a lack of in-house expertise and risk management advantages.

Card outsourcing is fast-moving towards the adoption of cloud technology and onshore and nearshore models, driven primarily by cost advantage and government initiatives such as tax benefits respectively. In addition, there is an increased focus on value added services such as behavior analysis and fraud prevention schemes.

Card issuers remain responsible for their business actions, even though the vendor is given the authority to act on their behalf. Outsourced operations must be monitored closely to ensure adherence to a contractual agreement.

One of the best ways of judging the perceived quality of performance is communicating with those firms already doing business with the vendor. Card issuers can also engage in market research and take advice from professional advisors.

Spanning over 74 pages, 12 tables and 39 figures, “ 2020 Foresight Report: Best Practices in Card Outsourcing ” report report provides a comprehensive analysis of the key outsourcing activities in the card industry across the globe and explains the potential scope of outsourcing of key business operations associated with cards along with best practice case examples.

In addition to covering the Strategic Insight into Card Outsourcing, Best Practices in Vendor Management (Client Position in an Outsourcing Relationship, Vendor Selection, Vendor Agreement), Best Practice in Outsourcing Business Operations (Technology, Customer Service, Risk Management and Collections, Operations, Sales and Marketing and Loyalty Programs). The report covers 34 companies; Citibank, Barclays, Bank of America, Chase Bank, Genpact, TCS, Cognizant, Infosys, WNS, Vantiv, CyberSource, Wells Fargo, Intesa Sanpaolo Card, Capital One, American, Express, HDFC ICICI, HEW Federal Credit Union ,Reliance Bank Fiserv, Bank of India, Swisscard AECS AG, Acquirer Systems, Firstsource, Banco Santander, CallCredit, Public Service Credit Union, TSYS, First Data, FIS, Krung Thai Card, Cold Stone Creamery ,American State Bank and Golden Plains Credit Union.

Why You Should Buy This Report

  • Gain an comprehensive understanding of the market by reviewing a strategic insight into Card Outsourcing.
  • Learn about the best practices in Vendor Management and use this to plan for the future.
  • Find out more about the best practices in outsourcing business operations in order to remain as profitable as possible.
  • Stay a step ahead of your competitors by gaining an insight into the market through case studies within your industry.

Related reports

2020 Foresight Report: No Magic Bullet – Wealth Management Models

2020 Foresight Report: Best Practices in Managing the Credit Risk Cycle

2020 Foresight Report: Branding and Segmentation in Wealth Management

2020 Foresight Report: Social Media in Wealth Management

2020 Foresight Report: Mobile Point of Sale Technology

2020 Foresight Report: Merchant-Funded Rewards – Challenges and Opportunities for Retail Banks

Find all Debit / Credit Cards industry reports under a single page at:  Debit / Credit Cards industry reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Prostate Cancer – Pipeline Review, H2 2013, New Report Launched

Prostate Cancer – Pipeline Review, H2 2013 report provides an overview of the indication’s therapeutic pipeline. This report also reviews key players involved in the therapeutic development for Prostate Cancer. Prostate Cancer – Pipeline Review, Half Year is built using data and information sourced from publisher proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by publisher team.

Scope

  • A snapshot of the global therapeutic scenario for Prostate Cancer.
  • A review of the Prostate Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Prostate Cancer pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Prostate Cancer.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Prostate Cancer pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Spanning over 413 pages, 271 tables and 14 figures, “Prostate Cancer – Pipeline Review, H2 2013” report provides information on the therapeutic development for Prostate Cancer, complete with latest updates, and special features on late-stage and discontinued projects.

In addition to covering the Prostate Cancer Overview, Late Stage Products, Mid Clinical Stage Products, Early Clinical Stage Products, Discovery and Pre-Clinical Stage Products, Companies Involved in Prostate Cancer Therapeutics Development, Prostate Cancer Therapeutics – Drug Profile Updates, Prostate Cancer Therapeutics – Discontinued Products, Prostate Cancer Therapeutics – Dormant Products, Prostate Cancer – Product Development Milestones.  The report covers 185 companies; few are Bio-Path Holdings, Inc., ZIOPHARM Oncology, Inc., Millennium Pharmaceuticals, Inc., Novartis AG, Aphios Corporation, Astellas Pharma Inc., BioMarin Pharmaceutical Inc., GTx, Inc., Nippon Shinyaku Co., Ltd., Orion Corporation, Pfizer Inc., SuperGen, Inc., Anavex Life Sciences Corp., ValiRx Plc, Active Biotech AB, AEterna Zentaris Inc.

Find all Pharma & Healthcare Industry Reports under a single page at: Pharma and Healthcare Market Research Reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Hepatitis C – Pipeline Review, H2 2013, New Report Launched

Hepatitis C – Pipeline Review, H2 2013 report provides an overview of the indication’s therapeutic pipeline. This report also reviews key players involved in the therapeutic development for Hepatitis C. Hepatitis C – Pipeline Review, Half Year is built using data and information sourced from publisher proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by publisher team.

Scope

  • A snapshot of the global therapeutic scenario for Hepatitis C.
  • A review of the Hepatitis C products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Hepatitis C pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Hepatitis C.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Hepatitis C pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Spanning over 291 pages, 177 tables and 14 figures, “ Hepatitis C – Pipeline Review, H2 2013 ” report provides information on the therapeutic development for Hepatitis C, complete with latest updates, and special features on late-stage and discontinued projects.

In addition to covering the Hepatitis C Overview, Hepatitis C Therapeutics under Development by Companies, Hepatitis C Therapeutics under Investigation by Universities/Institutes, Late Stage Products, Mid Clinical Stage Products, Early Clinical Stage Products, Discovery and Pre-Clinical Stage Products, Companies Involved in Hepatitis C Therapeutics Development, Hepatitis C Therapeutics – Drug Profile Updates, Hepatitis C Therapeutics – Discontinued Products, Hepatitis C Therapeutics – Dormant Products, Hepatitis C – Product Development Milestones. The report covers 121 companies; few are Raptor Pharmaceuticals Corp., NeuroVive Pharmaceutical AB, Intas Pharmaceuticals Ltd., Digna Biotech, S.L., Debiopharm Group, Functional Genetics, Inc., StemCells, Inc., SCYNEXIS, Inc., Nutri Pharma ASA, Imgenex Corp., ImmunoBiology Limited, Altor BioScience Corporation, Anacor Pharmaceuticals, Inc., Pt. Bio Farma. Find all: Diseases Market Research Reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Rheumatoid Arthritis – Pipeline Review, H2 2013, New Report Launched

Rheumatoid Arthritis – Pipeline Review, H2 2013 report provides an overview of the indication’s therapeutic pipeline. This report also reviews key players involved in the therapeutic development for Rheumatoid Arthritis. Rheumatoid Arthritis – Pipeline Review, Half Year is built using data and information sourced from publisher proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by publisher team.

Scope

  • A snapshot of the global therapeutic scenario for Rheumatoid Arthritis.
  • A review of the Rheumatoid Arthritis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Rheumatoid Arthritis pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Rheumatoid Arthritis.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Rheumatoid Arthritis pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Spanning over 392 pages, 277 tables and 14 figures, “Rheumatoid Arthritis – Pipeline Review, H2 2013” report provides information on the therapeutic development for Rheumatoid Arthritis, complete with latest updates, and special features on late-stage and discontinued projects.

In addition to covering the Rheumatoid Arthritis Overview, Rheumatoid Arthritis Therapeutics under Development by Companies, Rheumatoid Arthritis Therapeutics under Investigation by Universities/Institutes, Drug Profiles, Rheumatoid Arthritis Therapeutics – Drug Profile Updates, Rheumatoid Arthritis Therapeutics – Discontinued Products, Rheumatoid Arthritis Therapeutics – Dormant Products, Rheumatoid Arthritis – Product Development Milestones.  The report covers 201 companies; few are Alcon, Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Biogen Idec Inc., Amgen Inc., Antares Pharma, Inc., AstraZeneca PLC, Eli Lilly and Company, GlaxoSmithKline plc, Inovio Biomedical Corporation. Find all: Healthcare Market Research Reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Non-Small Cell Lung Cancer – Pipeline Review, H2 2013, New Report Launched

Non-Small Cell Lung Cancer – Pipeline Review, H2 2013 report provides an overview of the indication’s therapeutic pipeline. This report also reviews key players involved in the therapeutic development for Non-Small Cell Lung Cancer. Non-Small Cell Lung Cancer – Pipeline Review, Half Year is built using data and information sourced from publisher  proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by publisher team. For more information visit: Non-Small Cell Lung Cancer – Pipeline Review, H2 2013

Scope

  • A snapshot of the global therapeutic scenario for Non-Small Cell Lung Cancer.
  • A review of the Non-Small Cell Lung Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Non-Small Cell Lung Cancer pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Non-Small Cell Lung Cancer.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Non-Small Cell Lung Cancer pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Spanning over 447 pages, 234 tables and 14 figures, “Non-Small Cell Lung Cancer – Pipeline Review, H2 2013”  report provides information on the therapeutic development for Non-Small Cell Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects.

In addition to covering the Non-Small Cell Lung Cancer Overview, Non-Small Cell Lung Cancer Therapeutics under Development by Companies, Non-Small Cell Lung Cancer Therapeutics under Investigation by Universities/Institutes, Late Stage Products, Mid Clinical Stage Products, Early Clinical Stage Products, Discovery and Pre-Clinical Stage Products, Companies Involved in Non-Small Cell Lung Cancer Therapeutics Development, Non-Small Cell Lung Cancer Therapeutics – Drug Profile Updates, Non-Small Cell Lung Cancer Therapeutics – Discontinued Products, Non-Small Cell Lung Cancer Therapeutics – Dormant Products, Non-Small Cell Lung Cancer – Product Development Milestones.  The report covers 138 companies; few are Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Biogen Idec Inc., Shionogi & Co., Ltd., Amgen Inc., Sanofi-Aventis, AstraZeneca PLC, Eli Lilly and Company, GlaxoSmithKline plc, Genentech, Inc., Nektar Therapeutics, Inovio Biomedical Corporation, MedImmune LLC.

Find all: Pharma and Healthcare Market Research Reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

MarketResearchReports.com: Alzheimer’s Disease – Pipeline Review, H2 2013, New Report Launched

Alzheimer’s Disease – Pipeline Review, H2 2013 report provides an overview of the indication’s therapeutic pipeline. This report also reviews key players involved in the therapeutic development for Alzheimer’s Disease. Alzheimer’s Disease – Pipeline Review, Half Year is built using data and information sourced from publisher proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by publisher team.

Scope

  • A snapshot of the global therapeutic scenario for Alzheimer’s Disease.
  • A review of the Alzheimer’s Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Alzheimer’s Disease pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Identify and understand important and diverse types of therapeutics under development for Alzheimer’s Disease.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding Alzheimer’s Disease pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Spanning over 297 pages, 260 tables and 10 figures, “ Alzheimer’s Disease – Pipeline Review, H2 2013 ” report provides information on the therapeutic development for Alzheimer’s Disease, complete with latest updates, and special features on late-stage and discontinued projects.

In addition to covering the Alzheimer’s Disease Overview, Late Stage Products, Mid Clinical Stage Products, Early Clinical Stage Products, Discovery and Pre-Clinical Stage Products, Companies Involved in Alzheimer’s Disease Therapeutics Development, Alzheimer’s Disease Therapeutics – Drug Profile Updates, Alzheimer’s Disease Therapeutics – Discontinued Products, Alzheimer’s Disease Therapeutics – Dormant Products. The report covers 170 companies; few are Bristol-Myers Squibb Company, Johnson & Johnson, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche Ltd., Biogen Idec Inc., OXIS International, Inc., Shionogi & Co., Ltd., NsGene A/S, Amgen Inc., Sanofi-Aventis, AstraZeneca PLC, Eli Lilly and Company. Find all: Pharma and Healthcare Market Research Reports

About Market Research Reports, Inc.

Market Research Reports, Inc. (www.MarketResearchReports.com) is the world’s leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.